• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Evaluation of Ebola virus disease surveillance system capability to promptly detect a new outbreak in Liberia - BMJ Global Health

Mary Wilson

Well-known member
2 August 2023

http://dx.doi.org/10.1136/bmjgh-2023-012369

Fulton Quincy Shannon, II,1,2, Luke L Bawo,2 , John A Crump,1, Katrina Sharples,3, Richard Egan,4, Philip C Hill,1

ABSTRACT

Introduction
Liberia was heavily affected by the 2014– 2016 Ebola virus disease (EVD) outbreak. With substantial investments in interventions to combat future outbreaks, it is hoped that Liberia is well prepared for a new incursion. We assessed the performance of the current EVD surveillance system in Liberia, focusing on its ability to promptly detect a new EVD outbreak.

Methods
We integrated WHO and US Centers for Disease Control and Prevention guidelines for public health surveillance system evaluation and used standardised indicators to measure system performance. We conducted 23 key informant interviews, 150 health facility assessment surveys and a standardised patient (SP) study (19 visits) from January 2020 to January 2021. Data were summarised and a gap analysis conducted.

Results
We found basic competencies of case detection and reporting necessary for a functional surveillance system were in place. At the higher (national, county
and district) levels, we found performance gaps in 2 of 6 indicators relating to surveillance system structure, 3 of 14 indicators related to core functions, 1 of 5 quality indicators and 2 of 8 indicators related to support functions. The health facility assessment found performance gaps in 9 of 10 indicators related to core functions, 5 of 6 indicators related to support functions and 3 of 7 indicators related to quality. The SP simulations revealed large gaps between expected and actual practice in managing a patient warranting investigation for EVD. Major challenges affecting the system’s operations across all levels included limited access to resources to support surveillance activities, persistent stock out of sample collection materials and attrition of trained staff.

Conclusion
The EVD surveillance system in Liberia may fail to promptly detect a new EVD outbreak. Speci c improvements are required, and regular evaluations recommended. SP studies could be crucial in evaluating surveillance systems for rarely occurring diseases that are important to detect early.

https://gh.bmj.com/content/bmjgh/8/8/e012369.full.pdf?with-ds=yes

 
Back
Top